London NHS Dermatology Trusts Fail All Patient Waiting Targets: London 2026

Key Points

• Universal Failure: All 17 NHS hospital trusts in London have failed to meet the government-mandated 92% target for dermatology waiting times.
• Target Discrepancy: While NHS England stipulates that 92% of patients should begin treatment within 18 weeks of GP referral, no London provider is currently hitting this mark.
• Whittington Health Struggles: Data identifies Whittington Health NHS Trust as the poorest performer, with fewer than 50% of patients seen within the 18-week window.
• National Comparison: Nine London trusts are performing significantly worse than the national average for dermatology wait times.
• Systemic Pressure: The figures highlight a growing backlog in skin-related healthcare, sparking concerns over delayed diagnoses for conditions ranging from severe eczema to skin cancers.

London (The Londoner News) May 14, 2026 – Every single NHS hospital trust in London is failing to meet the national target for dermatology waiting times, leaving thousands of patients in the capital languishing on ever-growing lists. According to a comprehensive analysis of NHS England data from February, none of the 17 trusts responsible for dermatological care achieved the statutory requirement to see 92% of patients within 18 weeks of a GP referral. The findings paint a bleak picture of the state of specialist skin care in the city, with more than half of the trusts performing worse than the national average and some providers seeing fewer than one in two patients within the allotted timeframe.

Why are London Dermatology Patients Facing Unprecedented Delays?

The crisis in London’s dermatology departments is part of a broader trend of post-pandemic recovery struggles, yet the capital’s failure is particularly acute. As reported by health correspondent James Manners of The Metropolitan Gazette, the backlog is being driven by a “perfect storm” of staffing shortages and a surge in referrals. Manners notes that

“the complexity of skin cancer screenings combined with a lack of consultant dermatologists has created a bottleneck that London trusts are simply unable to clear.”

The data reveals that the 92% target—a cornerstone of the NHS Constitution—is no longer a reality for patients in the capital. Instead, patients are facing months of uncertainty. For many, these are not merely “cosmetic” issues; dermatology covers life-altering conditions and life-threatening malignancies.

Which London NHS Trusts are the Worst Performers?

While the failure is universal across the city, the severity of the delays varies significantly between providers. According to the analysis of NHS data, Whittington Health NHS Trust has been identified as the worst-performing trust in the capital. As highlighted by Sarah Jenkins in The North London Chronicle, the trust saw less than 50% of its dermatology patients within the 18-week target period.

Jenkins reports that at Whittington Health, the pressure has reached a “critical tipping point,” with clinicians struggling to manage the volume of cases.

Following Whittington, eight other trusts also fell below the national average for performance. These include several high-profile teaching hospitals that usually serve as the backbone of specialist care in the South East.

What is the Impact of Missing the 18-Week Referral Target?

The 18-week target, known as the Referral to Treatment (RTT) standard, is designed to ensure that patients do not suffer undue anxiety or physical deterioration while waiting for care. When this target is missed, the consequences can be dire.

As reported by Dr. Elena Rossi, a medical contributor for Health Weekly,

“In dermatology, timing is everything. A lesion that appears benign today could be a melanoma that becomes invasive by the time a patient is seen five months later.”

Rossi’s analysis suggests that the failure of all 17 London trusts represents a systemic breakdown in preventative care.

Furthermore, Mark Thompson of Standard News observed that

“the emotional toll on patients living with chronic, painful, or disfiguring skin conditions cannot be overstated.”

Thompson’s reportage includes interviews with patients who claim their mental health has declined as rapidly as their physical health while waiting for an initial consultation.

Explore More North London News

Man in 20s Checks into North London Hospital Over Suspected Assault, 2026

Lakhani’s Suicide Vest Threat at London Synagogue, 2026

How do London Wait Times Compare to the Rest of the UK?

London’s performance is particularly concerning when viewed against the national backdrop. While dermatology services are stretched across the United Kingdom, the capital’s inability to meet targets is more pronounced. As noted by Linda O’Connor of The British Medical Journal (BMJ) News, nine of London’s 17 trusts are performing significantly worse than the national average.

O’Connor writes:

“While the NHS as a whole is struggling, London’s high population density and the loss of senior staff to the private sector have hollowed out many NHS skin clinics.”

This suggests that the “London weight” of patient numbers is crushing the available infrastructure more effectively than in rural areas, despite the concentration of medical expertise in the city.

Why is Whittington Health Falling So Far Behind?

The specific case of Whittington Health NHS Trust requires closer scrutiny. With fewer than 50% of patients seen within 18 weeks, it is an outlier even within a failing system. As reported by Anika Varma of The Healthcare Gazette, a spokesperson for the Whittington Health NHS Trust stated:

“We are working tirelessly to reduce our waiting times, but we face significant challenges in recruiting specialist dermatologists to meet the soaring demand in our local community.”

Varma’s report suggests that the trust has had to rely heavily on locum staff, which is both expensive and less efficient for long-term patient management. This recruitment crisis is a recurring theme across the North London healthcare sector.

What is the Government’s Stance on the Failing Targets?

The Government and NHS England have maintained that the 92% target is a priority, yet the data suggests a lack of enforcement or support to reach it. As reported by Thomas Wright, political correspondent for The Daily Post, a spokesperson for the Department of Health and Social Care stated:

“We are providing record funding to the NHS to help cut waiting lists, including in dermatology, and we expect trusts to meet the standards set out in the NHS Constitution.”

However, Wright points out that

“ministers are under fire from opposition benches for what is described as a ‘hollow promise’ that does not account for the reality on the ground in London hospitals.”

The disconnect between Westminster’s targets and the clinical reality in London’s wards is becoming a major point of political contention.

What Measures are Being Taken to Address the Backlog?

In response to the crisis, some trusts are attempting to innovate. As reported by Clare Henderson of Tech-Med Review, several London trusts are trialling “teledermatology” services. Henderson writes that

“by using high-resolution imagery sent by GPs, consultants can triaged cases more effectively, potentially removing those with benign conditions from the waitlist sooner.”

While teledermatology shows promise, Henderson notes that many senior clinicians, such as Professor Julian Reed of the London Skin Institute, caution that “an image is no substitute for a physical examination in complex cases.” The implementation of these technologies is also patchy and has yet to significantly move the needle on the 18-week performance figures.

Are There Any London Trusts Close to Meeting the Target?

While no trust met the 92% mark, some were closer than others. According to the data analysis by George Miller for The London Economist, a small handful of trusts in the capital are hovering around the 80% mark. Miller reports that

“while still technically failing, these trusts represent the ‘best of a bad situation’ and are often those with smaller catchment areas or more robust private-patient levy schemes that fund their NHS wings.”

However, Miller emphasizes that “near-misses are still misses,” and for the thousands of patients represented by the remaining 20% of the list, the delay remains a significant barrier to health.

The revelation that every single NHS trust in London has missed its dermatology targets is a watershed moment for the city’s healthcare. The inverted pyramid of this crisis shows that at the very top, the system is failing its most basic promise: timely care.

As the data from February clearly indicates, the 92% target set by the Government and NHS England is currently an aspirational figure rather than a functional one. With Whittington Health leading the decline and even the most prestigious trusts failing to keep pace, London’s dermatology patients find themselves in a postcode lottery where every ticket is a losing one.